The fragile-X mental retardation syndrome, one of the most prevalent chromosome X-linked diseases (,1 of 2000 newborn males), is characterized by the presence in affected males and in a portion of carrier females of a fragile site at chromosome band Xq27. We have performed a linkage analysis in 16 families between the locus for the fragile-X syndrome, FRAXQ27, and two polymorphic DNA markers that correspond to the anonymous probe Stl4 and to the coagulation factor IX gene F9. Our results indicate that the order of loci is centromere-F9-FRAXQ27-Stl4-Xqter. The estimate of the recombination fraction for the linkage F9-FRAXQ27 is 0.12 (90% confidence limits: 0.044-0.225) and 0.10 for FRAX-Q27-Stl4 (90% confidence limits: 0.040-0.185). Recombination between Stl4 and F9 does not appear to be significantly different in normal and fragile-X families. The two flanking probes were used for diagnosis of the carrier state and for detection of transmission of the disease through phenotypically normal males. They should also allow first-trimester diagnosis with a reliability of about 98% in 40% of the families. Used in conjunction with the cytogenetic analysis, the segregation studies with both probes should improve the genetic counseling for the fragile-X syndrome and should be useful for the formal genetic analysis of this unique disease.
The fragile-X mental retardation syndrome (fragile-X syndrome) accounts for one-quarter to one-third of families with chromosome X-linked mental retardation, and it is present in approximately 1 of 2000 newborn males. It may also account for 3-4% of all mental retardation in otherwise normal females. The fragile-X syndrome is a pleiotropic trait consisting of (i) the presence of a fragile site on the X chromosome at the q27-q28 interface, induced in vitro by thymidine deprivation, (ii) a variable degree of mental retardation in hemizygous males, usually accompanied by characteristic physical features, and (iii) a 35% risk of mental impairment in heterozygous females (see refs. [1] [2] [3] .
The genetics of the fragile-X syndrome departs from classic chromosome X-linked inheritance in several respects. The gene for the fragile-X syndrome, FRAXQ27, does not appear to be fully penetrant in males. Apparently normal males (cytogenetically and/or clinically) can transmit the disease, as first suggested from retrospective analysis of large pedigrees (reviewed in refs. 1 and 2). On the other hand, the percentage of clinically expressing females is much higher than in other sex-linked diseases.
The diagnosis of carrier females is difficult because only about one-half of the females who carry the fragile-X mutation can be detected by their phenotype (mental retardation and/or fragile-site expression) (4) . Prenatal diagnosis can be performed by assaying for the fragile site in fetal cells obtained by amniocentesis (5) , fetal blood sampling (6) , and more recently by microvilli biopsy (7) . The first two techniques can be performed in only a few centers because of the difficulty of detection of the fragile site in amniocytes or the greater obstetrical complexity of fetal blood sampling compared to amniocentesis. The reliability of fragile-site detection in trophoblast cells is not yet documented. Thus, because of the prevalence of the disease and of the problems encountered for genetic counseling, it is important to improve the methods for carrier detection and prenatal diagnosis. Other aspects of the formal genetics of the fragile-X syndrome appear intriguing. A segregation analysis suggested that the mutation rate at this locus is very high (7.2 x 10-4), but that mutations occur only in sperm (4). The gene seems to be more penetrant in the offspring of daughters of transmitting males than in offspring of mothers of transmitting males (20) .
Segregation analysis with restriction fragment length polymorphism (RFLP) linked to the disease locus could be very useful in investigating such problems, since these markers allow the assessment of the genotype of individuals. In this paper, we report a linkage analysis between the fragile-X syndrome locus FRAXQ27 and two probes located in the q27-qter region of the human X chromosome. We have reported that RFLP within the coagulation factor IX gene F9 was closely linked to FRAXQ27 and could detect transmission through normal males (8) . Here we show that F9 and a very polymorphic locus defined by the anonymous probe Stl4 (9) flank the disease locus. We illustrate the use of the two probes for the detection ofcarrier women or normal male transmitters. The two probes should be useful for prenatal diagnosis at present in about 40% of the families.
MATERIALS AND METHODS Preparation of DNA and Blot Hybridization. Total genomic DNA was extracted from human leukocytes or cultured cells, digested to completion with restriction endonucleases, fractionated by electrophoresis on 0.9% agarose gels as described (10) , and blotted onto diazobenzyloxymethyl paper (11) .
Probes. The probe for the coagulation factor IX gene F9 was a 5.5-kilobase (kb) EcoRI genomic fragment called FIX P1, cloned in X1149, and screened with a coagulation factor IX cDNA probe (12) . It contains exons b, c, and d and neighboring introns and detects a Taq I polymorphism (13) .
For the StJ4 locus, we first used a 9.3-kb probe (Stl4.9) that detects at least 10 allelic fragments in DNAs digested with Taq I and three independent RFLPs with the enzyme Msp I Abbreviations: RFLP, restriction fragment length polymorphism; kb, kilobase(s); fragile-X syndrome, fragile-X mental retardation syndrome. **To whom reprint requests should be addressed.
Proc. Natl. Acad. Sci. USA 83 (1986) 1017 (9 Fragile-X Families. Pedigrees and cytogenetic data for the families 3, 4, and 13 have been published (8, 14, 15) . The cytogenetic analysis in 13 other families was carried out as described (14, 16 (4) . Second, unambiguous male transmitters were entered as affected, the status of cytogenetically normal adult women was considered as unknown, and a high penetrance value (0.9) was tested for younger females (under 18), since it is likely that most of the carriers are detected when cytogenetic analysis is carried out in this age category. (In our pedigree set, out of 25 young females at 50% risk of being carrier, 13 showed the fragile site; see also refs. 18 and 19.) The lod scores (logarithm of odds of linkage) obtained for each family, as calculated with model A (see Table 1 ) are presented in Fig. 2 for F9-FRAXQ27 and from 7.90 to 9.50 for StJ4-FRAXQ27 (Table 1) . In both cases, the highest lod score value was obtained when the least ambiguity (model G) was attributed to the genotype of normal individuals at the fragile-X syndrome locus-i.e., high penetrance for young females and, as suggested (20) Fig. 3 , where the sister (IV10) of an affected male asked for genetic counseling on the occasion of a pregnancy. She was clinically and cytogenetically normal, with thus a 30% chance only of being a carrier (assuming a penetrance of 0.56). She has received from her doubly heterozygous mother F9 and StJ4 alleles that are different from those of her affected brother or cousins. Risk calculation shows that her final risk of being a carrier is only 1.3%. In the same family, the demonstration that transmission occurred through a male (114, see below) implies that II18 is a carrier. Her cytogenetically normal daughter has a probability of about 76% of being a carrier since she inherited the F9 allele from the grandfather (the Stl4 locus is not informative in this case because 1118 is homozygous for this marker).
Detection of Probable Male Transmitters. In several families the segregation analysis strongly suggested transmission through a male. In family 1 (Fig. 3) , where the right part of the family was analyzed first, all three affected males have inherited the allele combination of the maternal grandfather. Further enquiry revealed that the half-sister II11 of this man was the grandmother of two affected cases, IV3 and IV5. Thus, male transmission was demonstrated unequivocally. In other cases, such pedigree evidence was not available. In family 2, individuals of generation III with fragile-X have inherited the A-5 combination while unaffected males have the a-1 combination (Fig. 4) . It is unlikely that the disease was transmitted through the grandmother, for it would imply at least three recombination events between F9 and FRAXQ27.
On the contrary, no recombination would have occurred if the grandfather was the carrier of the mutation. In family 14, the mother of affected children (112) was heterozygous for the Table 1 ). Tests of heterogeneity were performed as described by Morton (22) : XI-, = (21n 10) (E P -2) where Zi is the maximum lod score for the jth family and 2 is the maximum lod score for the whole set of families. (Fig. 4) . In the three sibs of generation III, the FRAXQ27 mutation appears to segregate with the a allele, which comes from the grandfather. It is very unlikely (about 1 chance in 400) that the grandmother was a carrier, which would require three recombination events in three meioses. This suggests that the grandfather was a silent carrier or that a new mutation occurred in sperm.
DISCUSSION
We have performed an analysis of linkage between a locus associated with a prevalent chromosome X-linked disease, the fragile-X syndrome, and two polymorphic loci detected by DNA probes previously mapped in the q27-qter region of the X chromosome. In our study, most families were informative for both polymorphic markers; therefore, we analyzed the three loci jointly, for it is more efficient than pairwise linkage to infer gene order (23) . It was important to take into account different, incomplete penetrances in males and females, which are particular features of this syndrome. For instance, in three-generation families, the knowledge of the genotype of the maternal grandfather at the marker loci does not always yield the phase as with other chromosome X-linked diseases, since he might be a "normal" carrier (see families 1 and 13) . The FRAXQ27 penetrance in males was estimated as 80% by Sherman et al., but it might be higher in sibships with affected males (20) . The determination of the carrier status in females is also difficult: only about 56% of carrier females show clinical or cytogenetic signs of the FRAXQ27 mutation. This value is age dependent and, young females apparently exhibit the fragile site in a much greater proportion of the cases (18, 19) .
We have analyzed the data under various assumptions. Penetrance was varied from 0.8 to 0.95 in males. We used a penetrance value of 0.56 for females of all ages, or, alternatively, we used a penetrance value of0.9 for girls under 18 and scored adult women as phenotypically unknown. Although the odds in favor of linkage vary with the various modes of calculation (Table 1) , the recombination fraction estimate remains stable. This is also true for gene order: with higher penetrance values in males and/or females, the most likely order is preserved, but odds in its favor are increased.
Our estimate of recombination between F9 and FRAXQ27 is 0.12 (90% confidence limits of 0.04 to 0.22). Although our first study (8) had suggested that the two loci might be closer, we had pointed out that the 90% confidence limits were 0-12% recombination. Meanwhile, Choo et al. (24) published an analysis of five families showing approximately 15% recombination (5 of29 or 4 of 23, depending on whether or not normal females were taken into account), similar to the value found in our study. The Stl4 locus also displays about 10% recombination with FRAXQ27 with a maximum lod score of 9.5 (90% confidence limits of 0.04-0.18). The three-point linkage analysis as well as simple examination of large nuclear pedigree (Fig. 1) places FRAXQ27 between the two marker loci. Since a similar conclusion has been reached by in situ hybridization of the FIX and Stl4 probes to chromosomes displaying the fragile site at Xq27, this supports further the notion that the mutation is located in the same region as the cytogenetically demonstrable fragile site (25) .
The multilocus linkage data can be used to investigate two important questions. First, is there genetic heterogeneity in fragile-X families-i.e., can the data be explained by the existence of a single locus? Linkage analysis does not provide evidence for heterogeneity among families as tested by the method of Morton (22) (Table 2 ; see, however, Note Added in Proof). Second, does the presence of the FRAXQ27 mutation affect recombination in the telomeric region of the X chromosome? It has been proposed that the fragile site region exhibits a high frequency of recombination in normal families, since the two probes 52A and FIX P1 mapping in q27 by in situ hybridization are at 0.30 recombination unit from the cluster of loci in q28 that includes those defined by probes DX13 and Stl4 and the G6PD (glucose-6-phosphate dehydrogenase) and HEMA (hemophilia A) loci (9, 26) . Szabo et al. (27) have suggested that the recombination fraction Genetics: Oberle' et al.
Proc. Natl. Acad. Sci. USA 83 (1986) between F9 and the G6PD cluster is much smaller in fragile-X families. The present data do not support the hypothesis of Szabo et al. because the recombination fraction between Stl4 and F9 in fragile-X families, as estimated from three-locus analysis, is about 0.19 (or 0.22 when estimated from twopoint linkage data), whereas there was 28% recombination in normal families. A x2 test showed that these differences are not significant (Table 2) . Part of the discrepancy with the conclusions presented by Szabo et al. (27) derives from their use of our initial linkage data (8) , which suggested closer linkage between the F9 and FRAXQ27 loci.
Our results establish the validity of the StJ4 and F9 markers as tools in the genetic analysis in fragile-X families. They flank the disease locus and can be used in conjunction with cytogenetic tests for prenatal diagnosis and carrier detection in families informative at both loci. Given the recombination fraction between each test locus and the FRAXQ27 locus, double recombinants should occur in only 1-2% of the meioses in the Stl4-F9 interval. The heterozygosity for the combined Taq I and Dde I RFLPs detected by the FIX P1 probe is 60% in Caucasians (28) , while that of the Taq I and Msp I RFLPs at the Stl4 locus is about 90% (9) . Thus, 54% of the families would be doubly informative. However, in 25-30o of the cases, a single recombination event will occur between the two marker loci, which will prevent diagnosis. Therefore, we estimate that about 40% of Caucasian cases could benefit from a segregation analysis with the two probes.
The marker study can also help to detect new mutations (as shown for hemophilia A; unpublished data) and/or those families in which the disease was transmitted through normal males. Out of the 16 families analyzed, families 3 and 4 were known to have normal male transmitters, based on the pedigree alone (a conclusion only possible for large pedigrees). In family 13, the F9 segregation data were sufficient to establish male transmission beyond doubt (8) , and the Stl4 segregation data confirm this conclusion. In family 1 the F9 segregation data also suggested male transmission, which was confirmed by further pedigree analysis (Fig. 3) . Suggestive evidence for male transmission (or for a neomutation arising in a male) has been obtained in two other families (families 2 and 14, Fig. 4 (9, 27) , it might be difficult to find probes genetically closer unless they are physically in the immediate vicinity of the mutation.
Note Added in Proof. Since submission of this manuscript, Brown et al. (29) have reported finding significant heterogeneity among families for the recombination fraction between F9 and FRAXQ27 loci when using Morton 
